Santen Pharmaceutical Company (PK) (SNPHY)
USOTC
Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories -- Parion has a plan for the first clinical...
Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology PR Newswire SAN DIEGO and OSAKA, Japan, March 4, 2014 SAN DIEGO and OSAKA, Japan, March...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.825 | 7.83475783476 | 10.53 | 11.6423 | 10.4 | 7110 | 10.48474515 | DR |
4 | -0.275 | -2.36457437661 | 11.63 | 12 | 9.86 | 7043 | 10.84967437 | DR |
12 | -1.305 | -10.308056872 | 12.66 | 13 | 9.86 | 4059 | 11.39059918 | DR |
26 | 0.95 | 9.13022585296 | 10.405 | 13 | 9.58 | 7884 | 11.48370624 | DR |
52 | 1.815 | 19.0251572327 | 9.54 | 13 | 8.95 | 6485 | 10.91153276 | DR |
156 | -1.135 | -9.08726981585 | 12.49 | 13 | 6.2 | 30929 | 9.49522988 | DR |
260 | -7.197 | -38.7936610608 | 18.552 | 20.93 | 6.2 | 32679 | 12.0971881 | DR |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約